Viewing Study NCT01992159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT01992159
Status: COMPLETED
Last Update Posted: 2019-03-25
First Post: 2013-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 20101291
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators